CoLucid Pharmaceuticals Garners $4,750,000 New Financing Round

  • Feed Type
  • Date
    7/12/2013
  • Company Name
    CoLucid Pharmaceuticals
  • Mailing Address
    P.O. Box 14401 Durham, NC 27709 USA
  • Company Description
    CoLucid Pharmaceuticals is an innovative biotechnology company focusing on therapies for central nervous system (CNS) disorders. CoLucid is leading a paradigm shift in migraine therapy with the clinical development of a first-in-class Neurally Acting Anti-Migraine Agent (NAAMA).
  • Website
    http://www.colucid.com
  • Transaction Type
    Debt
  • Transaction Amount
    $4,750,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy